Ep 18: Acute Kidney Injury (AKI): Part 2

Learning Objectives

By the end of this episode, NICU Grads will be able to:
1. Review how to manage neonates with nAKI
2. Discuss how the presence of nAKI affects risk of CKD
3. List how to conduct kidney health surveillance for high-risk NICU graduates

Guest Speakers 
Matthew W. Harer MD
 
Neonatologist and Assistant Professor of Pediatrics University of Wisconsin School of Medicine and Public Health 
PI of Harer Research Group 
Neonatal Kidney Collaborative (NKC) Communications Co-Chair 
Twitter- @TripleBadger10
Website- https://www.pediatrics.wisc.edu/research/research-groups/harer/

Dr. Matthew Harer completed his undergraduate studies at the University of Wisconsin-Madison, and is a 2010 graduate from the University of Wisconsin School of Medicine and Public Health. He completed his Pediatric residency at the University of Wisconsin Hospital and Clinics and his Neonatology fellowship in 2016 at the University of Virginia in Charlottesville where he also earned a certificate of Public Health. Dr. Harer is an accomplished researcher and is well published in journals including the Journal of Perinatology, Pediatric Nephrology,  and JAMA Pediatrics, among others. He is the current PI of the Harer Research Group conducting translational research on neonatal kidney function. He currently has grant funding through the Wisconsin Partnership Program investigating non-invasive diagnosis of acute kidney injury in premature infants and a KL2 award through the National Institutes of Health investigating renal tissue oxygenation monitoring in preterm neonates for the early detection of AKI. Dr. Harer has presented locally, nationally and internationally on a variety of topics including neonatal kidney development and function, treatment of positive urine cultures in the NICU and the effect of caffeine on preterm infant renal tissue oxygenation among others.

Michelle Starr MD, MPH 
Pediatric Nephrologist, Indiana University School of Medicine and Riley Children’s Hospital 
Assistant Professor of Pediatrics, Division of Pediatric Nephrology and Pediatric & Adolescent Comparative Effectiveness Research Program 
Neonatal Kidney Health Program (PI) at Riley Hospital for Children Neonatal Kidney Collaborative (NKC) Communications Co-Chair 
Twitter- @mcstarr1 
Website- https://medicine.iu.edu/faculty/44360/starr-michelle

Dr. Michelle Starr is an Assistant Professor of Pediatrics with joint appointments in Pediatric Nephrology and Pediatric & Adolescent Comparative Effectiveness Research. She received her medical degree from Tufts University School of Medicine as well as a Masters degree in Public Health from Tufts University School of Public Health. She completed Pediatric Residency and Chief Residency, as well as Pediatric Nephrology Fellowship at University of Washington and Seattle Children’s Hospital. Dr. Starr’s clinical and research interests lie in improving the kidney-related outcomes of children born prematurely, with a particular focus on acute kidney injury in the Neonatal Intensive Care Unit. Dr. Starr has published her work in JAMA, Pediatric Nephrology, Journal of Perinatology and Perinatology. She is the PI of the Neonatal Kidney Health Program at Riley Hospital for Children, which cares for neonates with kidney injury during their neonatal hospitalization and following discharge. Dr. Starr is currently pursuing research to further explore the relationship between kidney injury and bronchopulmonary dysplasia in premature infants. Dr. Starr has presented locally, nationally and internationally on a variety of topics including neonatal kidney disease and acute kidney injury, renal replacement therapy in neonates, and the role of kidney injury in the development of lung disease in premature infants.

Credits

  • Written and Produced by: Neena Jube-Desai MD, MBA FAAP
  • Editor: Neena Jube-Desai MD, MBA FAAP
  • Host: Neena Jube-Desai MD, MBA FAAP
  • Guests: Matthew W. Harer MD and Michelle Starr MD, MPH
  • Cover Art by: Neena Jube-Desai MD, MBA FAAP